시장보고서
상품코드
1838834

후생유전체학 시장 분석 및 예측(-2034년) : 유형, 제품, 서비스, 기술, 용도, 최종사용자, 구성요소, 프로세스

Epigenomics Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Component, Process

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 400 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

후생유전체학 시장은 2024년 34억 달러에서 2034년 116억 달러로 약 13.1%의 CAGR로 성장할 것으로 예상됩니다. 후성유전체학 시장에는 DNA 염기서열을 바꾸지 않고 유전자 발현에 영향을 미치는 DNA 메틸화, 히스톤 변형과 같은 후생유전학적 변형을 연구하는 기술 및 솔루션이 포함됩니다. 이 시장에는 맞춤형 의료와 종양학의 발전에 힘입어 연구, 진단 및 치료 도구가 포함됩니다. 질병 병인의 후생유전학적 기전에 대한 이해가 깊어짐에 따라 의약품 개발 및 바이오마커 발굴에 대한 기술 혁신이 촉진되고 있으며, 정밀의료가 헬스케어에서 점점 더 중요해짐에 따라 시장은 크게 성장할 것으로 보입니다.

후성유전체학 시장은 맞춤형 의료의 발전과 만성질환 유병률 증가에 힘입어 큰 폭의 성장세를 보이고 있습니다. 제품 분야, 특히 시약과 키트는 후생유전학 연구와 진단에서 중요한 역할을 하기 때문에 성과를 선도하고 있습니다. 시퀀서 및 분석기를 포함한 장비는 정확하고 효율적인 데이터 수집의 필요성을 반영하여 근소한 차이로 그 뒤를 잇고 있습니다. 응용 분야에서는 암 연구와 치료의 개별화에 대한 관심이 높아짐에 따라 암 분야가 우위를 점하고 있습니다. 심혈관계 질환, 대사성 질환 등 비종양학 분야가 견인력을 얻고 있으며, 암 외에도 후생유전체학의 범위가 넓어지고 있음을 강조하고 있습니다. 에피유전체 데이터 분석 및 해석을 포함하는 서비스 부문은 데이터 기반 인사이트에 대한 전문 지식의 중요성을 강조하며 큰 폭의 성장세를 보이고 있습니다. 임상시험수탁기관(CRO)은 전문적인 서비스를 제공하고 연구 일정을 앞당기는 매우 중요한 플레이어로 부상하고 있습니다. 에피유전체 데이터 처리에서 인공지능의 통합은 정확성과 효율성을 높여 시장 상황을 변화시키고 있습니다. 종합적인 후생유전학적 프로파일링에 대한 수요는 지속적으로 증가하고 있으며, 이는 시장의 잠재력을 뒷받침하고 있습니다.

시장 세분화
유형 DNA 메틸화, 히스톤 변형, RNA 변성, 크로마틴 리모델링, 논코딩 RNA, 에피제네틱 효소, 에피제네틱 리더, 에피제네틱 라이터, 에피제네틱 이레이서
제품 시약, 키트, 기기, 소프트웨어, 효소, 항체, 어레이, 시퀀싱 서비스
서비스 에피유전체맙핑, 바이오인포매틱스 솔루션, 컨설팅 서비스, 커스텀 서비스
기술 차세대 시퀀싱, 중합효소 연쇄 반응, 질량 분석, 크로마틴 면역침강, 바이설파이트 시퀀싱, 마이크로어레이
용도 종양학, 심혈관질환, 신경질환, 대사성 질환, 면역학, 발생생물학, 감염증, 농업
최종사용자 학술연구기관, 제약회사, 바이오테크놀러지 기업, 계약 연구기관, 진단 연구소
컴포넌트 하드웨어, 소프트웨어, 서비스
프로세스 조사, 임상시험, 진단, 의약품 개발

시장 스냅샷

후생유전체학 시장은 시장 점유율, 가격 전략, 혁신 제품 도입에 있어 역동적으로 변화하고 있습니다. 주요 기업들은 새로운 기회를 포착하기 위해 제품 포트폴리오를 강화하는 데 주력하고 있습니다. 이 때문에 경쟁사와의 가격 전략이 급증하고, 소비자 중심의 접근이 촉진되고 있습니다. 이 시장은 진단 및 치료제의 미충족 수요에 대응하기 위한 강력한 신제품 출시 파이프라인이 특징입니다. 선진적인 의료 시스템을 갖춘 지역이 이러한 발전의 최전선에 있으며, 기술 발전을 활용하여 시장 침투를 위해 노력하고 있습니다. 경쟁사 벤치마킹을 통해 소수의 주요 기업이 시장을 독점하고 신규 진입 기업이 틈새시장을 개척하려는 상황을 확인할 수 있었습니다. 북미, 유럽 등 지역에서는 엄격한 가이드라인이 제품 개발 및 승인 프로세스를 형성하고 있기 때문에 규제의 영향이 큽니다. 시장은 경쟁 우위를 유지하기 위해 필수적인 연구개발에 대한 투자 증가의 영향도 받고 있습니다. 전략적 제휴와 공동 연구가 활발히 이루어지고 있으며, 기업들은 연구 역량과 시장 진입을 확대하기 위해 노력하고 있습니다. 이러한 경쟁 환경은 규제의 역동성과 함께 전략적 민첩성과 혁신의 중요성을 강조하고 있습니다.

주요 동향과 촉진요인:

후생유전체학 시장은 맞춤형 의료의 발전과 암 발병률 증가에 힘입어 강력한 성장세를 보이고 있습니다. 정밀의료가 대중화됨에 따라 에피유전체 기술은 질병 진단과 치료에 필수적인 요소로 자리 잡으며 시장 성장을 주도하고 있습니다. 정부 자금과 연구 이니셔티브의 급격한 증가는 이러한 추세를 더욱 부추기고 있으며, 후생유전학적 메커니즘을 규명하기 위해 많은 투자가 이루어지고 있습니다. 시퀀싱 기술의 혁신으로 비용이 절감되고, 에피유전체 연구가 보다 친숙하고 광범위하게 이루어지고 있습니다. 이러한 기술의 민주화는 중요한 원동력이며, 소규모 연구기관이 이 분야에 기여할 수 있도록 하는 중요한 원동력이 되고 있습니다. 또한, 노화 관련 질병에 취약한 노년층 인구의 증가는 헬스케어에서 후생유전학의 중요성을 강조하고 있습니다. 제약회사들은 후성유전체 의약품이 치료 접근 방식에 혁명을 가져올 수 있다는 가능성을 인식하고 후성유전체 의약품 개발에 점점 더 집중하고 있습니다. 각 기업들이 후생유전학적 경로를 표적으로 하는 새로운 치료법 개발에 박차를 가하고 있는 가운데, 이러한 집중은 유리한 기회를 창출하고 있습니다. 후성유전체 데이터 분석에 인공지능을 통합하면 연구 역량을 더욱 향상시키고 새로운 인사이트를 제공하며 발견 과정을 가속화할 수 있습니다.

억제와 과제:

후성유전체학 시장에는 몇 가지 중요한 억제요인과 과제가 있습니다. 첫째, 고도의 후생유전학 연구 도구와 기술의 높은 비용, 특히 소규모 연구기관과 기업의 경우 진입장벽이 높다는 점입니다. 둘째, 후생유전학적 데이터 해석이 복잡하기 때문에 전문 지식이 필요하지만, 전문 지식이 부족하여 연구 개발 속도가 제한되어 있습니다. 셋째, 규제상의 어려움과 에피유전체 연구 및 응용에 대한 표준화된 가이드라인의 부재는 기업에게 불확실성을 가져와 시장의 안정성과 성장에 영향을 미칩니다. 넷째, 유전자 및 후성유전체 데이터의 프라이버시 및 보안에 대한 윤리적 우려는 소비자와 이해관계자들 사이에 불안감을 불러일으키고 보급을 방해할 수 있습니다. 마지막으로, 에피유전체 데이터를 기존 임상 워크플로우 및 전자의무기록과 통합하는 것은 여전히 기술적 과제이며, 연구 결과를 실용적인 헬스케어 솔루션으로 전환하는 것을 복잡하게 만들고 있습니다. 이러한 요인들이 종합적으로 후생유전체학 시장의 빠른 성장을 저해하고 있습니다.

주요 기업

Zymo Research, Active Motif, Diagenode, Epigentek, New England Biolabs, BaseClear, Twist Bioscience, Cambridge Epigenetix, EpiGentek Group, SomaLogic, Epicypher, Oxford Nanopore Technologies, Qiagen, Abcam, PerkinElmer

목차

제1장 후생유전체학 시장 개요

  • 조사 목적
  • 후생유전체학 시장 정의와 조사 범위
  • 보고서의 한계
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 주요 인사이트

제4장 후생유전체학 시장 전망

  • 후생유전체학 시장 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 후생유전체학 시장 전략

  • 상부 시장 분석
  • 수급 분석
  • 소비자 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 후생유전체학 시장 규모

  • 후생유전체학 시장 규모 : 금액별
  • 후생유전체학 시장 규모 : 수량별

제7장 후생유전체학 시장 : 유형별

  • 시장 개요
  • DNA 메틸화
  • 히스톤 변형
  • RNA 변성
  • 크로마틴 리모델링
  • 논코딩 RNA
  • 에피제네틱 효소
  • 에피제네틱 리더
  • 에피제네틱 라이터
  • 에피제네틱 이레이서
  • 기타

제8장 에피유전체 시장 : 제품별

  • 시장 개요
  • 시약
  • 키트
  • 기기
  • 소프트웨어
  • 효소
  • 항체
  • 어레이
  • 시퀀싱 서비스
  • 기타

제9장 후생유전체학 시장 : 서비스별

  • 시장 개요
  • 에피유전체맙핑
  • 바이오인포매틱스 솔루션
  • 컨설팅 서비스
  • 커스텀 서비스
  • 기타

제10장 후생유전체학 시장 : 기술별

  • 시장 개요
  • 차세대 시퀀싱
  • 중합효소 연쇄 반응
  • 질량 분석
  • 크로마틴 면역침강법
  • 바이설파이트 시퀀싱
  • 마이크로어레이
  • 기타

제11장 후생유전체학 시장, 용도별

  • 시장 개요
  • 종양학
  • 심혈관질환
  • 신경질환
  • 대사질환
  • 면역학
  • 발생생물학
  • 감염증학
  • 농업
  • 기타

제12장 후생유전체학 시장 : 최종사용자별

  • 시장 개요
  • 학술·연구기관
  • 제약회사
  • 바이오테크놀러지 기업
  • 수탁연구기관
  • 진단 실험실
  • 기타

제13장 후생유전체학 시장 : 구성요소별

  • 시장 개요
  • 하드웨어
  • 소프트웨어
  • 서비스
  • 기타

제14장 후생유전체학 시장 : 프로세스별

  • 시장 개요
  • 조사
  • 임상시험
  • 진단
  • 의약품 개발
  • 기타

제15장 후생유전체학 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트
    • 남아프리카공화국
    • 기타 중동 및 아프리카

제16장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략 벤치마킹

제17장 기업 개요

  • Zymo Research
  • Active Motif
  • Diagenode
  • Epigentek
  • New England Biolabs
  • BaseClear
  • Twist Bioscience
  • Cambridge Epigenetix
  • EpiGentek Group
  • SomaLogic
  • Epicypher
  • Oxford Nanopore Technologies
  • Qiagen
  • Abcam
  • PerkinElmer
KSM 25.11.04

Epigenomics Market is anticipated to expand from $3.4 billion in 2024 to $11.6 billion by 2034, growing at a CAGR of approximately 13.1%. The Epigenomics Market encompasses technologies and solutions for studying epigenetic modifications, such as DNA methylation and histone modification, impacting gene expression without altering the DNA sequence. This market includes tools for research, diagnostics, and therapeutics, driven by advancements in personalized medicine and oncology. The growing understanding of epigenetic mechanisms in disease etiology is propelling innovation in drug development and biomarker discovery, positioning the market for significant growth as precision medicine becomes increasingly pivotal in healthcare.

The Epigenomics Market is experiencing significant growth, propelled by advancements in personalized medicine and increasing prevalence of chronic diseases. The product segment, particularly reagents and kits, leads in performance due to their essential role in epigenetic research and diagnostics. Instruments, including sequencers and analyzers, follow closely, reflecting the need for precise and efficient data collection. Within the application segment, oncology dominates, driven by the rising focus on cancer research and treatment personalization. Non-oncology applications, such as cardiovascular and metabolic diseases, are gaining traction, highlighting the expanding scope of epigenomics beyond cancer. The services segment, encompassing epigenomic data analysis and interpretation, is witnessing substantial growth, emphasizing the importance of expertise in data-driven insights. Contract research organizations (CROs) are emerging as pivotal players, offering specialized services and accelerating research timelines. The integration of artificial intelligence in epigenomic data processing is enhancing accuracy and efficiency, marking a transformative shift in the market's landscape. The demand for comprehensive epigenetic profiling continues to rise, underscoring the market's potential.

Market Segmentation
TypeDNA Methylation, Histone Modification, RNA Modification, Chromatin Remodeling, Non-coding RNA, Epigenetic Enzymes, Epigenetic Readers, Epigenetic Writers, Epigenetic Erasers
ProductReagents, Kits, Instruments, Software, Enzymes, Antibodies, Arrays, Sequencing Services
ServicesEpigenomic Mapping, Bioinformatics Solutions, Consulting Services, Custom Services
TechnologyNext-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, Chromatin Immunoprecipitation, Bisulfite Sequencing, Microarray
ApplicationOncology, Cardiovascular Diseases, Neurological Disorders, Metabolic Diseases, Immunology, Developmental Biology, Infectious Diseases, Agriculture
End UserAcademic and Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Diagnostic Labs
ComponentHardware, Software, Services
ProcessResearch, Clinical Trials, Diagnostics, Drug Development

Market Snapshot:

The Epigenomics Market is witnessing dynamic shifts in market share, pricing strategies, and the introduction of innovative products. Key players are focusing on enhancing product portfolios to capture emerging opportunities. This has led to a surge in competitive pricing strategies, fostering a more consumer-centric approach. The market is characterized by a robust pipeline of new product launches, aimed at addressing unmet needs in diagnostics and therapeutics. Regions with advanced healthcare systems are at the forefront of these developments, leveraging technological advancements to enhance market penetration. Competition benchmarking reveals a landscape dominated by a few key players, with new entrants striving to carve out market niches. Regulatory influences are significant, as stringent guidelines in regions like North America and Europe shape product development and approval processes. The market is also influenced by increasing investments in research and development, which are crucial for maintaining competitive advantage. Strategic partnerships and collaborations are prevalent, enabling companies to expand their research capabilities and market reach. This competitive environment, coupled with regulatory dynamics, underscores the importance of strategic agility and innovation.

Geographical Overview:

The epigenomics market is witnessing significant growth across diverse regions, each characterized by unique dynamics. North America remains at the forefront, propelled by substantial investments in research and development and the presence of leading biotechnology firms. The region's robust healthcare infrastructure further supports the market's expansion. Europe is closely following, driven by strong governmental support and funding for genomic research. The emphasis on personalized medicine in the region enhances its market potential. In Asia Pacific, the market is expanding rapidly, boosted by increasing healthcare expenditure and a burgeoning biotechnology sector. Countries like China and India are emerging as key players due to their large patient populations and growing research capabilities. Latin America and the Middle East & Africa are also witnessing growth, albeit at a slower pace. Brazil and South Africa are emerging as new growth pockets, with increasing investments in healthcare research and infrastructure. These regions recognize the transformative potential of epigenomics in advancing personalized medicine and improving health outcomes.

Key Trends and Drivers:

The Epigenomics Market is experiencing robust expansion, propelled by advancements in personalized medicine and the increasing prevalence of cancer. As precision medicine gains traction, epigenomic technologies are becoming integral to disease diagnosis and treatment, driving market growth. The surge in government funding and research initiatives further fuels this trend, with significant investments directed towards understanding epigenetic mechanisms. Innovations in sequencing technologies have reduced costs, making epigenomic research more accessible and widespread. This democratization of technology is a key driver, enabling smaller research entities to contribute to the field. Additionally, the growing geriatric population, susceptible to age-related diseases, underscores the importance of epigenomics in healthcare. Pharmaceutical companies are increasingly focusing on epigenetic drug development, recognizing its potential to revolutionize therapeutic approaches. This focus is creating lucrative opportunities, as companies race to develop novel treatments targeting epigenetic pathways. The integration of artificial intelligence in epigenomic data analysis further enhances research capabilities, offering new insights and accelerating discovery processes.

Restraints and Challenges:

The epigenomics market encounters several significant restraints and challenges. Firstly, the high cost of advanced epigenetic research tools and technologies poses a substantial barrier to entry, particularly for smaller research institutions and companies. Secondly, the complexity of epigenetic data interpretation requires specialized expertise, which is in short supply, thereby limiting the pace of research and development. Thirdly, regulatory challenges and the lack of standardized guidelines for epigenomic research and applications create uncertainties for companies, affecting market stability and growth. Fourthly, ethical concerns surrounding genetic and epigenetic data privacy and security raise apprehensions among consumers and stakeholders, potentially hindering widespread adoption. Lastly, the integration of epigenomic data with existing clinical workflows and electronic health records remains a technical challenge, complicating the translation of research findings into practical healthcare solutions. These factors collectively impede the rapid expansion of the epigenomics market.

Key Players:

Zymo Research, Active Motif, Diagenode, Epigentek, New England Biolabs, BaseClear, Twist Bioscience, Cambridge Epigenetix, EpiGentek Group, SomaLogic, Epicypher, Oxford Nanopore Technologies, Qiagen, Abcam, PerkinElmer

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Epigenomics Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Epigenomics Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Component
  • 2.10 Key Highlights of the Market, by Process
  • 2.11 Key Highlights of the Market, by North America
  • 2.12 Key Highlights of the Market, by Europe
  • 2.13 Key Highlights of the Market, by Asia-Pacific
  • 2.14 Key Highlights of the Market, by Latin America
  • 2.15 Key Highlights of the Market, by Middle East
  • 2.16 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Component
  • 3.9 Market Attractiveness Analysis, by Process
  • 3.10 Market Attractiveness Analysis, by North America
  • 3.11 Market Attractiveness Analysis, by Europe
  • 3.12 Market Attractiveness Analysis, by Asia-Pacific
  • 3.13 Market Attractiveness Analysis, by Latin America
  • 3.14 Market Attractiveness Analysis, by Middle East
  • 3.15 Market Attractiveness Analysis, by Africa

4: Epigenomics Market Outlook

  • 4.1 Epigenomics Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Epigenomics Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Epigenomics Market Size

  • 6.1 Epigenomics Market Size, by Value
  • 6.2 Epigenomics Market Size, by Volume

7: Epigenomics Market, by Type

  • 7.1 Market Overview
  • 7.2 DNA Methylation
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Histone Modification
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 RNA Modification
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Chromatin Remodeling
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Non-coding RNA
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Epigenetic Enzymes
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Epigenetic Readers
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Epigenetic Writers
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Epigenetic Erasers
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region
  • 7.11 Others
    • 7.11.1 Key Market Trends & Opportunity Analysis
    • 7.11.2 Market Size and Forecast, by Region

8: Epigenomics Market, by Product

  • 8.1 Market Overview
  • 8.2 Reagents
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Kits
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Instruments
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Software
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Enzymes
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Antibodies
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Arrays
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Sequencing Services
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region
  • 8.10 Others
    • 8.10.1 Key Market Trends & Opportunity Analysis
    • 8.10.2 Market Size and Forecast, by Region

9: Epigenomics Market, by Services

  • 9.1 Market Overview
  • 9.2 Epigenomic Mapping
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Bioinformatics Solutions
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Consulting Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Custom Services
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Epigenomics Market, by Technology

  • 10.1 Market Overview
  • 10.2 Next-Generation Sequencing
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Polymerase Chain Reaction
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Mass Spectrometry
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Chromatin Immunoprecipitation
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Bisulfite Sequencing
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Microarray
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Others
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region

11: Epigenomics Market, by Application

  • 11.1 Market Overview
  • 11.2 Oncology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Cardiovascular Diseases
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Neurological Disorders
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Metabolic Diseases
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Immunology
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Developmental Biology
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region
  • 11.8 Infectious Diseases
    • 11.8.1 Key Market Trends & Opportunity Analysis
    • 11.8.2 Market Size and Forecast, by Region
  • 11.9 Agriculture
    • 11.9.1 Key Market Trends & Opportunity Analysis
    • 11.9.2 Market Size and Forecast, by Region
  • 11.10 Others
    • 11.10.1 Key Market Trends & Opportunity Analysis
    • 11.10.2 Market Size and Forecast, by Region

12: Epigenomics Market, by End User

  • 12.1 Market Overview
  • 12.2 Academic and Research Institutes
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Pharmaceutical Companies
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Biotechnology Companies
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Contract Research Organizations
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Diagnostic Labs
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: Epigenomics Market, by Component

  • 13.1 Market Overview
  • 13.2 Hardware
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Software
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Services
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Epigenomics Market, by Process

  • 14.1 Market Overview
  • 14.2 Research
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Clinical Trials
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Diagnostics
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Drug Development
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Others
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region

15: Epigenomics Market, by Region

  • 15.1 Overview
  • 15.2 North America
    • 15.2.1 Key Market Trends and Opportunities
    • 15.2.2 North America Market Size and Forecast, by Type
    • 15.2.3 North America Market Size and Forecast, by Product
    • 15.2.4 North America Market Size and Forecast, by Services
    • 15.2.5 North America Market Size and Forecast, by Technology
    • 15.2.6 North America Market Size and Forecast, by Application
    • 15.2.7 North America Market Size and Forecast, by End User
    • 15.2.8 North America Market Size and Forecast, by Component
    • 15.2.9 North America Market Size and Forecast, by Process
    • 15.2.10 North America Market Size and Forecast, by Country
    • 15.2.11 United States
      • 15.2.9.1 United States Market Size and Forecast, by Type
      • 15.2.9.2 United States Market Size and Forecast, by Product
      • 15.2.9.3 United States Market Size and Forecast, by Services
      • 15.2.9.4 United States Market Size and Forecast, by Technology
      • 15.2.9.5 United States Market Size and Forecast, by Application
      • 15.2.9.6 United States Market Size and Forecast, by End User
      • 15.2.9.7 United States Market Size and Forecast, by Component
      • 15.2.9.8 United States Market Size and Forecast, by Process
      • 15.2.9.9 Local Competition Analysis
      • 15.2.9.10 Local Market Analysis
    • 15.2.1 Canada
      • 15.2.10.1 Canada Market Size and Forecast, by Type
      • 15.2.10.2 Canada Market Size and Forecast, by Product
      • 15.2.10.3 Canada Market Size and Forecast, by Services
      • 15.2.10.4 Canada Market Size and Forecast, by Technology
      • 15.2.10.5 Canada Market Size and Forecast, by Application
      • 15.2.10.6 Canada Market Size and Forecast, by End User
      • 15.2.10.7 Canada Market Size and Forecast, by Component
      • 15.2.10.8 Canada Market Size and Forecast, by Process
      • 15.2.10.9 Local Competition Analysis
      • 15.2.10.10 Local Market Analysis
  • 15.1 Europe
    • 15.3.1 Key Market Trends and Opportunities
    • 15.3.2 Europe Market Size and Forecast, by Type
    • 15.3.3 Europe Market Size and Forecast, by Product
    • 15.3.4 Europe Market Size and Forecast, by Services
    • 15.3.5 Europe Market Size and Forecast, by Technology
    • 15.3.6 Europe Market Size and Forecast, by Application
    • 15.3.7 Europe Market Size and Forecast, by End User
    • 15.3.8 Europe Market Size and Forecast, by Component
    • 15.3.9 Europe Market Size and Forecast, by Process
    • 15.3.10 Europe Market Size and Forecast, by Country
    • 15.3.11 United Kingdom
      • 15.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 15.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 15.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 15.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 15.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 15.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 15.3.9.7 United Kingdom Market Size and Forecast, by Component
      • 15.3.9.8 United Kingdom Market Size and Forecast, by Process
      • 15.3.9.9 Local Competition Analysis
      • 15.3.9.10 Local Market Analysis
    • 15.3.1 Germany
      • 15.3.10.1 Germany Market Size and Forecast, by Type
      • 15.3.10.2 Germany Market Size and Forecast, by Product
      • 15.3.10.3 Germany Market Size and Forecast, by Services
      • 15.3.10.4 Germany Market Size and Forecast, by Technology
      • 15.3.10.5 Germany Market Size and Forecast, by Application
      • 15.3.10.6 Germany Market Size and Forecast, by End User
      • 15.3.10.7 Germany Market Size and Forecast, by Component
      • 15.3.10.8 Germany Market Size and Forecast, by Process
      • 15.3.10.9 Local Competition Analysis
      • 15.3.10.10 Local Market Analysis
    • 15.3.1 France
      • 15.3.11.1 France Market Size and Forecast, by Type
      • 15.3.11.2 France Market Size and Forecast, by Product
      • 15.3.11.3 France Market Size and Forecast, by Services
      • 15.3.11.4 France Market Size and Forecast, by Technology
      • 15.3.11.5 France Market Size and Forecast, by Application
      • 15.3.11.6 France Market Size and Forecast, by End User
      • 15.3.11.7 France Market Size and Forecast, by Component
      • 15.3.11.8 France Market Size and Forecast, by Process
      • 15.3.11.9 Local Competition Analysis
      • 15.3.11.10 Local Market Analysis
    • 15.3.1 Spain
      • 15.3.12.1 Spain Market Size and Forecast, by Type
      • 15.3.12.2 Spain Market Size and Forecast, by Product
      • 15.3.12.3 Spain Market Size and Forecast, by Services
      • 15.3.12.4 Spain Market Size and Forecast, by Technology
      • 15.3.12.5 Spain Market Size and Forecast, by Application
      • 15.3.12.6 Spain Market Size and Forecast, by End User
      • 15.3.12.7 Spain Market Size and Forecast, by Component
      • 15.3.12.8 Spain Market Size and Forecast, by Process
      • 15.3.12.9 Local Competition Analysis
      • 15.3.12.10 Local Market Analysis
    • 15.3.1 Italy
      • 15.3.13.1 Italy Market Size and Forecast, by Type
      • 15.3.13.2 Italy Market Size and Forecast, by Product
      • 15.3.13.3 Italy Market Size and Forecast, by Services
      • 15.3.13.4 Italy Market Size and Forecast, by Technology
      • 15.3.13.5 Italy Market Size and Forecast, by Application
      • 15.3.13.6 Italy Market Size and Forecast, by End User
      • 15.3.13.7 Italy Market Size and Forecast, by Component
      • 15.3.13.8 Italy Market Size and Forecast, by Process
      • 15.3.13.9 Local Competition Analysis
      • 15.3.13.10 Local Market Analysis
    • 15.3.1 Netherlands
      • 15.3.14.1 Netherlands Market Size and Forecast, by Type
      • 15.3.14.2 Netherlands Market Size and Forecast, by Product
      • 15.3.14.3 Netherlands Market Size and Forecast, by Services
      • 15.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 15.3.14.5 Netherlands Market Size and Forecast, by Application
      • 15.3.14.6 Netherlands Market Size and Forecast, by End User
      • 15.3.14.7 Netherlands Market Size and Forecast, by Component
      • 15.3.14.8 Netherlands Market Size and Forecast, by Process
      • 15.3.14.9 Local Competition Analysis
      • 15.3.14.10 Local Market Analysis
    • 15.3.1 Sweden
      • 15.3.15.1 Sweden Market Size and Forecast, by Type
      • 15.3.15.2 Sweden Market Size and Forecast, by Product
      • 15.3.15.3 Sweden Market Size and Forecast, by Services
      • 15.3.15.4 Sweden Market Size and Forecast, by Technology
      • 15.3.15.5 Sweden Market Size and Forecast, by Application
      • 15.3.15.6 Sweden Market Size and Forecast, by End User
      • 15.3.15.7 Sweden Market Size and Forecast, by Component
      • 15.3.15.8 Sweden Market Size and Forecast, by Process
      • 15.3.15.9 Local Competition Analysis
      • 15.3.15.10 Local Market Analysis
    • 15.3.1 Switzerland
      • 15.3.16.1 Switzerland Market Size and Forecast, by Type
      • 15.3.16.2 Switzerland Market Size and Forecast, by Product
      • 15.3.16.3 Switzerland Market Size and Forecast, by Services
      • 15.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 15.3.16.5 Switzerland Market Size and Forecast, by Application
      • 15.3.16.6 Switzerland Market Size and Forecast, by End User
      • 15.3.16.7 Switzerland Market Size and Forecast, by Component
      • 15.3.16.8 Switzerland Market Size and Forecast, by Process
      • 15.3.16.9 Local Competition Analysis
      • 15.3.16.10 Local Market Analysis
    • 15.3.1 Denmark
      • 15.3.17.1 Denmark Market Size and Forecast, by Type
      • 15.3.17.2 Denmark Market Size and Forecast, by Product
      • 15.3.17.3 Denmark Market Size and Forecast, by Services
      • 15.3.17.4 Denmark Market Size and Forecast, by Technology
      • 15.3.17.5 Denmark Market Size and Forecast, by Application
      • 15.3.17.6 Denmark Market Size and Forecast, by End User
      • 15.3.17.7 Denmark Market Size and Forecast, by Component
      • 15.3.17.8 Denmark Market Size and Forecast, by Process
      • 15.3.17.9 Local Competition Analysis
      • 15.3.17.10 Local Market Analysis
    • 15.3.1 Finland
      • 15.3.18.1 Finland Market Size and Forecast, by Type
      • 15.3.18.2 Finland Market Size and Forecast, by Product
      • 15.3.18.3 Finland Market Size and Forecast, by Services
      • 15.3.18.4 Finland Market Size and Forecast, by Technology
      • 15.3.18.5 Finland Market Size and Forecast, by Application
      • 15.3.18.6 Finland Market Size and Forecast, by End User
      • 15.3.18.7 Finland Market Size and Forecast, by Component
      • 15.3.18.8 Finland Market Size and Forecast, by Process
      • 15.3.18.9 Local Competition Analysis
      • 15.3.18.10 Local Market Analysis
    • 15.3.1 Russia
      • 15.3.19.1 Russia Market Size and Forecast, by Type
      • 15.3.19.2 Russia Market Size and Forecast, by Product
      • 15.3.19.3 Russia Market Size and Forecast, by Services
      • 15.3.19.4 Russia Market Size and Forecast, by Technology
      • 15.3.19.5 Russia Market Size and Forecast, by Application
      • 15.3.19.6 Russia Market Size and Forecast, by End User
      • 15.3.19.7 Russia Market Size and Forecast, by Component
      • 15.3.19.8 Russia Market Size and Forecast, by Process
      • 15.3.19.9 Local Competition Analysis
      • 15.3.19.10 Local Market Analysis
    • 15.3.1 Rest of Europe
      • 15.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 15.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 15.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 15.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 15.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 15.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 15.3.20.7 Rest of Europe Market Size and Forecast, by Component
      • 15.3.20.8 Rest of Europe Market Size and Forecast, by Process
      • 15.3.20.9 Local Competition Analysis
      • 15.3.20.10 Local Market Analysis
  • 15.1 Asia-Pacific
    • 15.4.1 Key Market Trends and Opportunities
    • 15.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 15.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 15.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 15.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 15.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 15.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 15.4.8 Asia-Pacific Market Size and Forecast, by Component
    • 15.4.9 Asia-Pacific Market Size and Forecast, by Process
    • 15.4.10 Asia-Pacific Market Size and Forecast, by Country
    • 15.4.11 China
      • 15.4.9.1 China Market Size and Forecast, by Type
      • 15.4.9.2 China Market Size and Forecast, by Product
      • 15.4.9.3 China Market Size and Forecast, by Services
      • 15.4.9.4 China Market Size and Forecast, by Technology
      • 15.4.9.5 China Market Size and Forecast, by Application
      • 15.4.9.6 China Market Size and Forecast, by End User
      • 15.4.9.7 China Market Size and Forecast, by Component
      • 15.4.9.8 China Market Size and Forecast, by Process
      • 15.4.9.9 Local Competition Analysis
      • 15.4.9.10 Local Market Analysis
    • 15.4.1 India
      • 15.4.10.1 India Market Size and Forecast, by Type
      • 15.4.10.2 India Market Size and Forecast, by Product
      • 15.4.10.3 India Market Size and Forecast, by Services
      • 15.4.10.4 India Market Size and Forecast, by Technology
      • 15.4.10.5 India Market Size and Forecast, by Application
      • 15.4.10.6 India Market Size and Forecast, by End User
      • 15.4.10.7 India Market Size and Forecast, by Component
      • 15.4.10.8 India Market Size and Forecast, by Process
      • 15.4.10.9 Local Competition Analysis
      • 15.4.10.10 Local Market Analysis
    • 15.4.1 Japan
      • 15.4.11.1 Japan Market Size and Forecast, by Type
      • 15.4.11.2 Japan Market Size and Forecast, by Product
      • 15.4.11.3 Japan Market Size and Forecast, by Services
      • 15.4.11.4 Japan Market Size and Forecast, by Technology
      • 15.4.11.5 Japan Market Size and Forecast, by Application
      • 15.4.11.6 Japan Market Size and Forecast, by End User
      • 15.4.11.7 Japan Market Size and Forecast, by Component
      • 15.4.11.8 Japan Market Size and Forecast, by Process
      • 15.4.11.9 Local Competition Analysis
      • 15.4.11.10 Local Market Analysis
    • 15.4.1 South Korea
      • 15.4.12.1 South Korea Market Size and Forecast, by Type
      • 15.4.12.2 South Korea Market Size and Forecast, by Product
      • 15.4.12.3 South Korea Market Size and Forecast, by Services
      • 15.4.12.4 South Korea Market Size and Forecast, by Technology
      • 15.4.12.5 South Korea Market Size and Forecast, by Application
      • 15.4.12.6 South Korea Market Size and Forecast, by End User
      • 15.4.12.7 South Korea Market Size and Forecast, by Component
      • 15.4.12.8 South Korea Market Size and Forecast, by Process
      • 15.4.12.9 Local Competition Analysis
      • 15.4.12.10 Local Market Analysis
    • 15.4.1 Australia
      • 15.4.13.1 Australia Market Size and Forecast, by Type
      • 15.4.13.2 Australia Market Size and Forecast, by Product
      • 15.4.13.3 Australia Market Size and Forecast, by Services
      • 15.4.13.4 Australia Market Size and Forecast, by Technology
      • 15.4.13.5 Australia Market Size and Forecast, by Application
      • 15.4.13.6 Australia Market Size and Forecast, by End User
      • 15.4.13.7 Australia Market Size and Forecast, by Component
      • 15.4.13.8 Australia Market Size and Forecast, by Process
      • 15.4.13.9 Local Competition Analysis
      • 15.4.13.10 Local Market Analysis
    • 15.4.1 Singapore
      • 15.4.14.1 Singapore Market Size and Forecast, by Type
      • 15.4.14.2 Singapore Market Size and Forecast, by Product
      • 15.4.14.3 Singapore Market Size and Forecast, by Services
      • 15.4.14.4 Singapore Market Size and Forecast, by Technology
      • 15.4.14.5 Singapore Market Size and Forecast, by Application
      • 15.4.14.6 Singapore Market Size and Forecast, by End User
      • 15.4.14.7 Singapore Market Size and Forecast, by Component
      • 15.4.14.8 Singapore Market Size and Forecast, by Process
      • 15.4.14.9 Local Competition Analysis
      • 15.4.14.10 Local Market Analysis
    • 15.4.1 Indonesia
      • 15.4.15.1 Indonesia Market Size and Forecast, by Type
      • 15.4.15.2 Indonesia Market Size and Forecast, by Product
      • 15.4.15.3 Indonesia Market Size and Forecast, by Services
      • 15.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 15.4.15.5 Indonesia Market Size and Forecast, by Application
      • 15.4.15.6 Indonesia Market Size and Forecast, by End User
      • 15.4.15.7 Indonesia Market Size and Forecast, by Component
      • 15.4.15.8 Indonesia Market Size and Forecast, by Process
      • 15.4.15.9 Local Competition Analysis
      • 15.4.15.10 Local Market Analysis
    • 15.4.1 Taiwan
      • 15.4.16.1 Taiwan Market Size and Forecast, by Type
      • 15.4.16.2 Taiwan Market Size and Forecast, by Product
      • 15.4.16.3 Taiwan Market Size and Forecast, by Services
      • 15.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 15.4.16.5 Taiwan Market Size and Forecast, by Application
      • 15.4.16.6 Taiwan Market Size and Forecast, by End User
      • 15.4.16.7 Taiwan Market Size and Forecast, by Component
      • 15.4.16.8 Taiwan Market Size and Forecast, by Process
      • 15.4.16.9 Local Competition Analysis
      • 15.4.16.10 Local Market Analysis
    • 15.4.1 Malaysia
      • 15.4.17.1 Malaysia Market Size and Forecast, by Type
      • 15.4.17.2 Malaysia Market Size and Forecast, by Product
      • 15.4.17.3 Malaysia Market Size and Forecast, by Services
      • 15.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 15.4.17.5 Malaysia Market Size and Forecast, by Application
      • 15.4.17.6 Malaysia Market Size and Forecast, by End User
      • 15.4.17.7 Malaysia Market Size and Forecast, by Component
      • 15.4.17.8 Malaysia Market Size and Forecast, by Process
      • 15.4.17.9 Local Competition Analysis
      • 15.4.17.10 Local Market Analysis
    • 15.4.1 Rest of Asia-Pacific
      • 15.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 15.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 15.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 15.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 15.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 15.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 15.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 15.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 15.4.18.9 Local Competition Analysis
      • 15.4.18.10 Local Market Analysis
  • 15.1 Latin America
    • 15.5.1 Key Market Trends and Opportunities
    • 15.5.2 Latin America Market Size and Forecast, by Type
    • 15.5.3 Latin America Market Size and Forecast, by Product
    • 15.5.4 Latin America Market Size and Forecast, by Services
    • 15.5.5 Latin America Market Size and Forecast, by Technology
    • 15.5.6 Latin America Market Size and Forecast, by Application
    • 15.5.7 Latin America Market Size and Forecast, by End User
    • 15.5.8 Latin America Market Size and Forecast, by Component
    • 15.5.9 Latin America Market Size and Forecast, by Process
    • 15.5.10 Latin America Market Size and Forecast, by Country
    • 15.5.11 Brazil
      • 15.5.9.1 Brazil Market Size and Forecast, by Type
      • 15.5.9.2 Brazil Market Size and Forecast, by Product
      • 15.5.9.3 Brazil Market Size and Forecast, by Services
      • 15.5.9.4 Brazil Market Size and Forecast, by Technology
      • 15.5.9.5 Brazil Market Size and Forecast, by Application
      • 15.5.9.6 Brazil Market Size and Forecast, by End User
      • 15.5.9.7 Brazil Market Size and Forecast, by Component
      • 15.5.9.8 Brazil Market Size and Forecast, by Process
      • 15.5.9.9 Local Competition Analysis
      • 15.5.9.10 Local Market Analysis
    • 15.5.1 Mexico
      • 15.5.10.1 Mexico Market Size and Forecast, by Type
      • 15.5.10.2 Mexico Market Size and Forecast, by Product
      • 15.5.10.3 Mexico Market Size and Forecast, by Services
      • 15.5.10.4 Mexico Market Size and Forecast, by Technology
      • 15.5.10.5 Mexico Market Size and Forecast, by Application
      • 15.5.10.6 Mexico Market Size and Forecast, by End User
      • 15.5.10.7 Mexico Market Size and Forecast, by Component
      • 15.5.10.8 Mexico Market Size and Forecast, by Process
      • 15.5.10.9 Local Competition Analysis
      • 15.5.10.10 Local Market Analysis
    • 15.5.1 Argentina
      • 15.5.11.1 Argentina Market Size and Forecast, by Type
      • 15.5.11.2 Argentina Market Size and Forecast, by Product
      • 15.5.11.3 Argentina Market Size and Forecast, by Services
      • 15.5.11.4 Argentina Market Size and Forecast, by Technology
      • 15.5.11.5 Argentina Market Size and Forecast, by Application
      • 15.5.11.6 Argentina Market Size and Forecast, by End User
      • 15.5.11.7 Argentina Market Size and Forecast, by Component
      • 15.5.11.8 Argentina Market Size and Forecast, by Process
      • 15.5.11.9 Local Competition Analysis
      • 15.5.11.10 Local Market Analysis
    • 15.5.1 Rest of Latin America
      • 15.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 15.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 15.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 15.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 15.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 15.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 15.5.12.7 Rest of Latin America Market Size and Forecast, by Component
      • 15.5.12.8 Rest of Latin America Market Size and Forecast, by Process
      • 15.5.12.9 Local Competition Analysis
      • 15.5.12.10 Local Market Analysis
  • 15.1 Middle East and Africa
    • 15.6.1 Key Market Trends and Opportunities
    • 15.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 15.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 15.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 15.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 15.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 15.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 15.6.8 Middle East and Africa Market Size and Forecast, by Component
    • 15.6.9 Middle East and Africa Market Size and Forecast, by Process
    • 15.6.10 Middle East and Africa Market Size and Forecast, by Country
    • 15.6.11 Saudi Arabia
      • 15.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 15.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 15.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 15.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 15.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 15.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 15.6.9.7 Saudi Arabia Market Size and Forecast, by Component
      • 15.6.9.8 Saudi Arabia Market Size and Forecast, by Process
      • 15.6.9.9 Local Competition Analysis
      • 15.6.9.10 Local Market Analysis
    • 15.6.1 UAE
      • 15.6.10.1 UAE Market Size and Forecast, by Type
      • 15.6.10.2 UAE Market Size and Forecast, by Product
      • 15.6.10.3 UAE Market Size and Forecast, by Services
      • 15.6.10.4 UAE Market Size and Forecast, by Technology
      • 15.6.10.5 UAE Market Size and Forecast, by Application
      • 15.6.10.6 UAE Market Size and Forecast, by End User
      • 15.6.10.7 UAE Market Size and Forecast, by Component
      • 15.6.10.8 UAE Market Size and Forecast, by Process
      • 15.6.10.9 Local Competition Analysis
      • 15.6.10.10 Local Market Analysis
    • 15.6.1 South Africa
      • 15.6.11.1 South Africa Market Size and Forecast, by Type
      • 15.6.11.2 South Africa Market Size and Forecast, by Product
      • 15.6.11.3 South Africa Market Size and Forecast, by Services
      • 15.6.11.4 South Africa Market Size and Forecast, by Technology
      • 15.6.11.5 South Africa Market Size and Forecast, by Application
      • 15.6.11.6 South Africa Market Size and Forecast, by End User
      • 15.6.11.7 South Africa Market Size and Forecast, by Component
      • 15.6.11.8 South Africa Market Size and Forecast, by Process
      • 15.6.11.9 Local Competition Analysis
      • 15.6.11.10 Local Market Analysis
    • 15.6.1 Rest of MEA
      • 15.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 15.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 15.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 15.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 15.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 15.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 15.6.12.7 Rest of MEA Market Size and Forecast, by Component
      • 15.6.12.8 Rest of MEA Market Size and Forecast, by Process
      • 15.6.12.9 Local Competition Analysis
      • 15.6.12.10 Local Market Analysis

16: Competitive Landscape

  • 16.1 Overview
  • 16.2 Market Share Analysis
  • 16.3 Key Player Positioning
  • 16.4 Competitive Leadership Mapping
    • 16.4.1 Star Players
    • 16.4.2 Innovators
    • 16.4.3 Emerging Players
  • 16.5 Vendor Benchmarking
  • 16.6 Developmental Strategy Benchmarking
    • 16.6.1 New Product Developments
    • 16.6.2 Product Launches
    • 16.6.3 Business Expansions
    • 16.6.4 Partnerships, Joint Ventures, and Collaborations
    • 16.6.5 Mergers and Acquisitions

17: Company Profiles

  • 17.1 Zymo Research
    • 17.1.1 Company Overview
    • 17.1.2 Company Snapshot
    • 17.1.3 Business Segments
    • 17.1.4 Business Performance
    • 17.1.5 Product Offerings
    • 17.1.6 Key Developmental Strategies
    • 17.1.7 SWOT Analysis
  • 17.2 Active Motif
    • 17.2.1 Company Overview
    • 17.2.2 Company Snapshot
    • 17.2.3 Business Segments
    • 17.2.4 Business Performance
    • 17.2.5 Product Offerings
    • 17.2.6 Key Developmental Strategies
    • 17.2.7 SWOT Analysis
  • 17.3 Diagenode
    • 17.3.1 Company Overview
    • 17.3.2 Company Snapshot
    • 17.3.3 Business Segments
    • 17.3.4 Business Performance
    • 17.3.5 Product Offerings
    • 17.3.6 Key Developmental Strategies
    • 17.3.7 SWOT Analysis
  • 17.4 Epigentek
    • 17.4.1 Company Overview
    • 17.4.2 Company Snapshot
    • 17.4.3 Business Segments
    • 17.4.4 Business Performance
    • 17.4.5 Product Offerings
    • 17.4.6 Key Developmental Strategies
    • 17.4.7 SWOT Analysis
  • 17.5 New England Biolabs
    • 17.5.1 Company Overview
    • 17.5.2 Company Snapshot
    • 17.5.3 Business Segments
    • 17.5.4 Business Performance
    • 17.5.5 Product Offerings
    • 17.5.6 Key Developmental Strategies
    • 17.5.7 SWOT Analysis
  • 17.6 BaseClear
    • 17.6.1 Company Overview
    • 17.6.2 Company Snapshot
    • 17.6.3 Business Segments
    • 17.6.4 Business Performance
    • 17.6.5 Product Offerings
    • 17.6.6 Key Developmental Strategies
    • 17.6.7 SWOT Analysis
  • 17.7 Twist Bioscience
    • 17.7.1 Company Overview
    • 17.7.2 Company Snapshot
    • 17.7.3 Business Segments
    • 17.7.4 Business Performance
    • 17.7.5 Product Offerings
    • 17.7.6 Key Developmental Strategies
    • 17.7.7 SWOT Analysis
  • 17.8 Cambridge Epigenetix
    • 17.8.1 Company Overview
    • 17.8.2 Company Snapshot
    • 17.8.3 Business Segments
    • 17.8.4 Business Performance
    • 17.8.5 Product Offerings
    • 17.8.6 Key Developmental Strategies
    • 17.8.7 SWOT Analysis
  • 17.9 EpiGentek Group
    • 17.9.1 Company Overview
    • 17.9.2 Company Snapshot
    • 17.9.3 Business Segments
    • 17.9.4 Business Performance
    • 17.9.5 Product Offerings
    • 17.9.6 Key Developmental Strategies
    • 17.9.7 SWOT Analysis
  • 17.10 SomaLogic
    • 17.10.1 Company Overview
    • 17.10.2 Company Snapshot
    • 17.10.3 Business Segments
    • 17.10.4 Business Performance
    • 17.10.5 Product Offerings
    • 17.10.6 Key Developmental Strategies
    • 17.10.7 SWOT Analysis
  • 17.11 Epicypher
    • 17.11.1 Company Overview
    • 17.11.2 Company Snapshot
    • 17.11.3 Business Segments
    • 17.11.4 Business Performance
    • 17.11.5 Product Offerings
    • 17.11.6 Key Developmental Strategies
    • 17.11.7 SWOT Analysis
  • 17.12 Oxford Nanopore Technologies
    • 17.12.1 Company Overview
    • 17.12.2 Company Snapshot
    • 17.12.3 Business Segments
    • 17.12.4 Business Performance
    • 17.12.5 Product Offerings
    • 17.12.6 Key Developmental Strategies
    • 17.12.7 SWOT Analysis
  • 17.13 Qiagen
    • 17.13.1 Company Overview
    • 17.13.2 Company Snapshot
    • 17.13.3 Business Segments
    • 17.13.4 Business Performance
    • 17.13.5 Product Offerings
    • 17.13.6 Key Developmental Strategies
    • 17.13.7 SWOT Analysis
  • 17.14 Abcam
    • 17.14.1 Company Overview
    • 17.14.2 Company Snapshot
    • 17.14.3 Business Segments
    • 17.14.4 Business Performance
    • 17.14.5 Product Offerings
    • 17.14.6 Key Developmental Strategies
    • 17.14.7 SWOT Analysis
  • 17.15 PerkinElmer
    • 17.15.1 Company Overview
    • 17.15.2 Company Snapshot
    • 17.15.3 Business Segments
    • 17.15.4 Business Performance
    • 17.15.5 Product Offerings
    • 17.15.6 Key Developmental Strategies
    • 17.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제